News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No news articles published in the past hour across markets, economy, global events, or politics.
  • Market-moving headlines were absent, suggesting limited news-driven volatility this hour.
  • No macroeconomic releases or central bank statements appeared in the past hour.
  • No major corporate earnings, deal announcements, or guidance updates were reported this hour.
  • No new geopolitical incidents, sanctions, or government policy shifts were reported in the last hour.
  • Expect muted market reactions until scheduled data or breaking news appears.

Latest Articles

Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance

Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance

Picard Medical, Inc., parent company of SynCardia Systems LLC, announced a 1-for-50 reverse stock split effective July 31, 2026, approved by stockholders to comply with NYSE American listing standards. The split aims to support continued listing compliance while positioning the company for growth, including commercial strategy execution for its Syn…

Anthropic + AMD: A Conviction Trade Toward a $1,000 Target

Anthropic + AMD: A Conviction Trade Toward a $1,000 Target

Anthropic's large-scale AI deployments could force enterprise customers to bulk-buy accelerators and custom CPUs; if AMD captures a meaningful share of that spend, the company can re-rate sharply. This trade is high-conviction and high-risk: entry at $165.00, stop at $140.00, target $1,000.00 over a long-term (180 trading days) horizon, with clearl…

AirJoule Technologies and Kubota Corporation Announce Deployments of Breakthrough Decentralized Water Infrastructure and Exclusive Sales Partnership to Unlock Water-Constrained U.S. Residential Development

AirJoule Technologies and Kubota Corporation Announce Deployments of Breakthrough Decentralized Water Infrastructure and Exclusive Sales Partnership to Unlock Water-Constrained U.S. Residential Development

AirJoule Technologies (NASDAQ: AIRJ) and Japan's Kubota Corporation have announced an exclusive sales partnership and initial deployments of AirJoule's water-from-air technology combined with Kubota's water infrastructure expertise in Texas and California. This collaboration aims to provide decentralized, reliable water solutions to multi-unit resi…

Buy Moog on Visible Earnings Momentum and Embedded Platform Growth

Buy Moog on Visible Earnings Momentum and Embedded Platform Growth

Moog (MOG.A) is a high-quality aerospace & defense supplier with visible earnings expansion, a strong balance sheet, and exposure to growing space and aircraft component markets. Technicals and elevated short interest set up a tactical long entry. We outline an actionable plan with entry, stop and target for a mid-term (45 trading days) trade.

TOP Financial Group Limited Announces Full Exercise of All Outstanding Warrants Following Cashless Exercise

TOP Financial Group Limited Announces Full Exercise of All Outstanding Warrants Following Cashless Exercise

TOP Financial Group Limited announced the complete exercise of its outstanding warrants on a cashless basis, resulting in the issuance of approximately 360.5 million new Class A ordinary shares and cancellation of all remaining warrants. The newly issued shares are restricted and subject to a six-month lock-up period. The company operates diversifi…

LONG TABLE GROWTH CORP. ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING ON OR ABOUT JULY 27, 2026

LONG TABLE GROWTH CORP. ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING ON OR ABOUT JULY 27, 2026

Long Table Growth Corp., a newly public blank check company focused on business combinations across various sectors, announces that its Class A ordinary shares and warrants will begin trading separately on Nasdaq starting around July 27, 2026. Units purchased in the IPO can be separated into individual components for trading, with registration clea…

Nayax to Report 2026 Q2 Earnings on August 10, 2026

Nayax to Report 2026 Q2 Earnings on August 10, 2026

Nayax Ltd., a global payments and commerce enablement platform listed on Nasdaq and the Tel Aviv Stock Exchange, announced it will release its Q2 2026 earnings on August 10, 2026, before U.S. markets open. The company will host two conference calls in English and Hebrew to discuss results. Nayax continues to focus on simplifying payments and enhanc…

TLX591-Tx ProstACT SELECT Study Published in Cancers Journal

TLX591-Tx ProstACT SELECT Study Published in Cancers Journal

Telix Pharmaceuticals announced the peer-reviewed publication of the ProstACT SELECT Phase 1 study results in the journal Cancers, confirming the effectiveness of 68Ga-PSMA-PET imaging to select patients for their lead prostate cancer therapy candidate, TLX591-Tx. The study highlights TLX591-Tx's differentiated clinical profile with good safety and…

Pentagon Says US War in Iran Has Reached $37.5 Billion; Urgent Funding Sought amid Lawmaker Skepticism

Pentagon Says US War in Iran Has Reached $37.5 Billion; Urgent Funding Sought amid Lawmaker Skepticism

U.S. Defense Secretary Pete Hegseth told lawmakers the cost of the United States’ war in Iran stands at $37.5 billion, a figure that includes current expenditures and projected costs through September 30. His testimony came at a contentious hearing in Washington, where members of both parties questioned the administration’s transparency and the bro…

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Dyne Therapeutics, a clinical-stage biotech company focusing on genetically driven neuromuscular diseases, announced a registered underwritten public offering of $300 million in common stock, with an option for underwriters to purchase an additional $45 million. The proceeds will support the company’s clinical and preclinical programs targeting dis…

FS Bancorp, Inc. Reports Second Quarter Net Income of $7.9 Million or $1.04 Per Diluted Share and Declares 54th Consecutive Quarterly Cash Dividend

FS Bancorp, Inc. Reports Second Quarter Net Income of $7.9 Million or $1.04 Per Diluted Share and Declares 54th Consecutive Quarterly Cash Dividend

FS Bancorp, Inc. reported net income of $7.9 million or $1.04 per diluted share for Q2 2026, marking a slight increase from the prior quarter and year-ago period. The company declared its 54th consecutive quarterly cash dividend of $0.29 per share, underscoring its commitment to shareholder returns. Total deposits decreased primarily due to a reduc…

Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference

Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference

Acrivon Therapeutics will present data on its proprietary AP3 platform and the clinical-stage drug ACR-2316, a novel WEE1/PKMYT1 inhibitor designed with this platform. The presentations highlight AP3’s ability to guide pathway-based drug design, demonstrating differentiated anti-tumor activity and early clinical responses including partial response…

Weatherford Announces Second Quarter 2026 Results

Weatherford Announces Second Quarter 2026 Results

Weatherford International plc reported a 4% sequential decline in Q2 2026 revenues to $1.105 billion, with net income dropping 64% sequentially to $39 million, impacted by geopolitical tensions in the Middle East. The company announced acquisition of NCS Multistage to enhance its completions portfolio and launched a new plan to redomesticate from I…

Astera Labs: Growth Is Real, Now Trade the Momentum with a Plan

Astera Labs: Growth Is Real, Now Trade the Momentum with a Plan

Astera Labs’ connectivity chips are squarely in the path of a massive data-center build-out. Strong revenue growth, meaningful free cash flow, and recent index inclusion have pushed the stock higher, but momentum is pullback-prone. This trade idea lays out a disciplined long entry, targets, and a stop that respect valuation while leaning into conti…

States and New York City Challenge EPA Over Relaxed HFC Deadlines

States and New York City Challenge EPA Over Relaxed HFC Deadlines

Eighteen states, Washington, D.C. and New York City filed a petition in the federal appeals court in Washington, D.C. seeking to overturn an Environmental Protection Agency rule that extends deadlines for phasing down hydrofluorocarbons. Plaintiffs say the change would increase greenhouse gas emissions and roll back commitments made under the Ameri…